ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
119.662,38
0,08%
S&P 500
5.431,60
-0,04%
US Dollar vs BRL
5,35964
0,17%
Bitcoin
66.420,63
0,35%
Brent Oil
82,275
0,00%
Registration Strip Icon for default Cadastre-se gratuitamente para obter cotações em tempo real, gráficos interativos, fluxo de opções ao vivo e muito mais.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. ASLAN Pharmaceuticals Ltd (ASLN)

  7. ASLAN Pharmaceuticals Ltd (ASLN) Notícias

ASLN

ASLAN Pharmaceuticals (ASLN)

ASLAN Pharmaceuticals Ltd
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:ASLN
DataHoraFonteTítuloCódigoCompanhia
14/06/202417:46Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ASLNASLAN Pharmaceuticals Ltd
12/06/202417:32Edgar (US Regulatory)Form F-3 - Registration statement by foreign private issuersNASDAQ:ASLNASLAN Pharmaceuticals Ltd
14/02/202418:45Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:ASLNASLAN Pharmaceuticals Ltd
18/08/202308:33Edgar (US Regulatory)Form 6-K/A - Report of foreign issuer [Rules 13a-16 and 15d-16]: [Amend]NASDAQ:ASLNASLAN Pharmaceuticals Ltd
06/07/202309:09Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:ASLNASLAN Pharmaceuticals Ltd
28/04/202308:29Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:ASLNASLAN Pharmaceuticals Ltd
26/04/202318:27Edgar (US Regulatory)Securities Registration (ads, Immediate) (f-6ef)NASDAQ:ASLNASLAN Pharmaceuticals Ltd
26/04/202317:28Edgar (US Regulatory)Small Company Offering and Sale of Securities Without Registration (d)NASDAQ:ASLNASLAN Pharmaceuticals Ltd
24/03/202308:33Edgar (US Regulatory)Annual and Transition Report (foreign Private Issuer) (20-f)NASDAQ:ASLNASLAN Pharmaceuticals Ltd
20/03/202318:21Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:ASLNASLAN Pharmaceuticals Ltd
03/03/202310:31Edgar (US Regulatory)Post-effective Amendment to a Previously Filed F-6. (f-6 Pos)NASDAQ:ASLNASLAN Pharmaceuticals Ltd
14/02/202318:02Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:ASLNASLAN Pharmaceuticals Ltd
03/11/202217:08Edgar (US Regulatory)Confidential Treatment Order (ct Order)NASDAQ:ASLNASLAN Pharmaceuticals Ltd
31/10/202207:15TipRanksH.C. Wainwright Sticks to Their Buy Rating for Aslan Pharmaceuticals (ASLN)NASDAQ:ASLNASLAN Pharmaceuticals Ltd
15/09/202207:15TipRanksH.C. Wainwright Remains a Buy on Aslan Pharmaceuticals (ASLN)NASDAQ:ASLNASLAN Pharmaceuticals Ltd
13/09/202217:06Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:ASLNASLAN Pharmaceuticals Ltd
15/08/202207:25TipRanksH.C. Wainwright Keeps Their Buy Rating on Aslan Pharmaceuticals (ASLN)NASDAQ:ASLNASLAN Pharmaceuticals Ltd
23/05/202207:26TipRanksAslan Pharmaceuticals (ASLN) Receives a Buy from H.C. WainwrightNASDAQ:ASLNASLAN Pharmaceuticals Ltd
28/03/202207:26TipRanksH.C. Wainwright Reaffirms Their Buy Rating on Aslan Pharmaceuticals (ASLN)NASDAQ:ASLNASLAN Pharmaceuticals Ltd
25/03/202208:54Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:ASLNASLAN Pharmaceuticals Ltd
06/08/202108:46Edgar (US Regulatory)Amended Annual and Transition Report (foreign Private Issuer) (20-f/a)NASDAQ:ASLNASLAN Pharmaceuticals Ltd
25/05/202108:30GlobeNewswire Inc.ASLAN Pharmaceuticals to Participate In Fireside Chat at Jefferies Virtual Healthcare ConferenceNASDAQ:ASLNASLAN Pharmaceuticals Ltd
11/05/202108:30GlobeNewswire Inc.ASLAN Pharmaceuticals Reports First Quarter 2021 Financial Results and Provides Corporate UpdateNASDAQ:ASLNASLAN Pharmaceuticals Ltd
05/05/202106:22GlobeNewswire Inc.ASLAN Pharmaceuticals to Present Data on ASLAN004 at Society for Investigative DermatologyNASDAQ:ASLNASLAN Pharmaceuticals Ltd
22/04/202108:51GlobeNewswire Inc.ASLAN Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Corporate UpdateNASDAQ:ASLNASLAN Pharmaceuticals Ltd
01/04/202107:13Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:ASLNASLAN Pharmaceuticals Ltd
26/03/202117:19Edgar (US Regulatory)Securities Registration (foreign Private Issuer) (f-3)NASDAQ:ASLNASLAN Pharmaceuticals Ltd
18/03/202108:27GlobeNewswire Inc.ASLAN Pharmaceuticals Appoints Dr Kathleen Metters as Independent DirectorNASDAQ:ASLNASLAN Pharmaceuticals Ltd
03/03/202102:42GlobeNewswire Inc.ASLAN Pharmaceuticals Announces Pricing of Public Offering of American Depositary SharesNASDAQ:ASLNASLAN Pharmaceuticals Ltd
01/03/202118:01GlobeNewswire Inc.ASLAN Pharmaceuticals Announces Proposed Public Offering of American Depositary SharesNASDAQ:ASLNASLAN Pharmaceuticals Ltd
 Apresentando as notícias mais relevantes sobre:NASDAQ:ASLN

Seu Histórico Recente

BOV
IBOV
Índice Bovespa
BOV
IDIV
Dividend
BOV
RRRP3
3R Petroleum Oleo E Gas ... ON
BOV
TOTS3
TOTVS ON
BOV
BPAC11
BTG PACTUAL UNT
BOV
CMIN3
CSN Mineracao S.A ON
BOV
HAGA3
HAGA ON
BOV
HOOT4
HOTEIS OTHON PN
BOV
BRBI11
BR PARTNERS UNT N2
BOV
PETR4
PETROBRAS PN
BOV
PRIO3
PETRORIO ON
BOV
RCSL3
RECRUSUL ON
BOV
VVEO3
CM Hospitalar ON
BOV
HBOR3
HELBOR ON
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Brasil
Empresa
Negócios
Popular
Obter o aplicativo
App Store
Google Play

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados